N@N

Revolutions Medical Completes Merger with Clear Image

^{Published on 2008-12-02 05:41:54 - Market Wire}
 

MOUNT PLEASANT, S.C.--([ BUSINESS WIRE ])--Revolutions Medical Corporation (OTCBB: RMCP) completes merger with Clear Image and now owns 100% of all its proprietary technological assets. This allows Revolutions Medical Corp to move ahead with the development and delivery of the platform for its breakthrough MRI software technologies. Rev Med's MRI software will be DICOM standard compatible and should easily be adaptable to current picture archival computer systems (PACS). Having MRI's viewed not only in black and white on current PACS but by using Rev Med's color and 3D automatic segmentation software, could boost the reliability and confidence of radiologists. It would almost be like watching color and 3D television compared to black and white. With more than 25 million MRI procedures per year, just considering 10% of these could use Rev Med's color and 3D automatic segmentation software represents significant potential revenue over the next few years.

"We are pleased to have the merger of Clear Image into our operations completed. This will clear the way for the validation of the automatic segmentation and 3D/Color MRI technologies over the coming months. These important technologies have the potential to give Rev Med a tremendous advantage in the marketplace," reported Ron Wheet, Chief Executive Officer of Revolutions Medical Corp. With this merger, Revolutions Medical should now be able to commercialize the following pivotal intellectual property which will provide the basis for a family of MRI image analysis and image searching product offerings:

I. Method of Diagnostic Coding Using Medical Image Data

II. System For and Method of for Performing a Medical Diagnosis

III. System for and Method of Increasing the Efficacy of a Diagnostic Review of Images

IIII. Three-Dimensional MRI results Using Automatic Segmentation

Auto Segmentation

Although segmentation is offered as a feature on MRI systems and workstations it is primarily dependent on time-consuming labor-intensive manual or poorly performing automatic means to delineate the segmentation. This limitation exists across all known 3-D packages and severely limits the clinical usefulness of 3-D technology in calculating measurement and volume functions that require high quality segmentation and registration. In the future, by using the registration functions along with the inherent color segmentation of ColorMRI a high performance auto segmentation solution could be developed. Clinically this will deliver a cost-effective means to create accurate 3-D representations capable of providing the resolution necessary to ascertain precise reliable measurements. This also will provide the accurate reliable volume measurements necessary to record changes in volume over time.

Tom O'Brien, President of Clear Image, Inc., states, "This merger with Revolutions Medical Corporation represents the culmination of a number of years of R&D and millions of dollars invested to date."

About Revolutions Medical Corporation

Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.